A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people with acute myeloid leukemia overcome resistance to one of the most common ...

Abstract: In this paper, we studied the multi-feature combination estimation approach of forest above ground biomass (AGB) using X-band InSAR and P-band PolInSAR data. We focus on a crucial step of ...

Investors in Recursion (NASDAQ: RXRX) seemed only mildly fazed by Wednesday’s series of company announcements. The artificial intelligence (AI)-based drug developer’s stock barely moved on Wednesday, ...

GameSpot may get a commission from retail offers. As you explore the school section of Silent Hill f, you'll eventually come across an objective that asks you to open a locker. You'll soon find out, ...

In a recent social media post, Peter Ray, senior director of medicinal chemistry at Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), drew attention to a new article in WIRED from Veronique Greenwood ...

Recursion's AI-enabled drug discovery platform continues to evolve, but this is yet to translate into meaningful clinical success. The recent cull of programs has further undermined investor ...